{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:27:45Z","timestamp":1784154465357,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009358","name":"Duchenne UK","doi-asserted-by":"crossref","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100009358","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009358","name":"Duchenne UK","doi-asserted-by":"crossref","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100009358","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Charlies Fund","award":["na"],"award-info":[{"award-number":["na"]}]},{"name":"Charlies Fund","award":["na"],"award-info":[{"award-number":["na"]}]},{"DOI":"10.13039\/501100004410","name":"TUBITAK","doi-asserted-by":"crossref","award":["2219-International Postdoctoral Research Fellowship Program for Turkish Citizens"],"award-info":[{"award-number":["2219-International Postdoctoral Research Fellowship Program for Turkish Citizens"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17137-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:29:43Z","timestamp":1758886183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models"],"prefix":"10.1038","volume":"15","author":[{"given":"Paola","family":"Mantuano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket Sonbas","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Putker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Boccanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Tanganyika-de Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisamaura","family":"Tulimiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fleur","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cappellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Van De Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Engelbeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbesh","family":"Pandeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice A.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seward","family":"Rutkove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"17137_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S. & Mercuri, E. Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Primers. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"17137_CR2","doi-asserted-by":"publisher","first-page":"1360224","DOI":"10.3389\/fgene.2024.1360224","volume":"15","author":"F Gatto","year":"2024","unstructured":"Gatto, F., Benemei, S., Piluso, G. & Bello, L. The complex landscape of DMD mutations: moving towards personalized medicine. Front. Genet. 15, 1360224 (2024).","journal-title":"Front. Genet."},{"key":"17137_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","volume":"5","author":"QQ Gao","year":"2015","unstructured":"Gao, Q. Q. & McNally, E. M. The dystrophin complex: structure, function, and implications for therapy. Compr. Physiol. 5, 1223\u20131239 (2015).","journal-title":"Compr. Physiol."},{"key":"17137_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and Gastrointestinal and nutritional management. Lancet Neurol. 17, 251\u2013267 (2018).","journal-title":"Lancet Neurol."},{"key":"17137_CR5","doi-asserted-by":"publisher","first-page":"e208112","DOI":"10.1212\/WNL.0000000000208112","volume":"102","author":"UJ Dang","year":"2024","unstructured":"Dang, U. J. et al. Efficacy and safety of Vamorolone over 48 weeks in boys with Duchenne muscular dystrophy: A randomized controlled trial. Neurology 102, e208112 (2024).","journal-title":"Neurology"},{"key":"17137_CR6","doi-asserted-by":"publisher","first-page":"dmm042903","DOI":"10.1242\/dmm.042903","volume":"13","author":"R Willmann","year":"2020","unstructured":"Willmann, R. et al. Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD advisory committee for therapeutics (TACT). Dis. Model. Mech. 13, dmm042903 (2020).","journal-title":"Dis. Model. Mech."},{"key":"17137_CR7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1126\/science.2662404","volume":"244","author":"P Sicinski","year":"1989","unstructured":"Sicinski, P. et al. The molecular basis of muscular dystrophy in the Mdx mouse: a point mutation. Science 244, 1578\u20131580 (1989).","journal-title":"Science"},{"key":"17137_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","volume":"31","author":"MD Grounds","year":"2008","unstructured":"Grounds, M. D., Radley, H. G., Lynch, G. S., Nagaraju, K. & De Luca, A. Towards developing standard operating procedures for pre-clinical testing in the Mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis. 31, 1\u201319 (2008).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"17137_CR9","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.1038\/s41598-020-74192-9","volume":"10","author":"RT Massopust","year":"2020","unstructured":"Massopust, R. T. et al. Lifetime analysis of Mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss. Sci. Rep. 10 (1), 17248 (2020).","journal-title":"Sci. Rep."},{"key":"17137_CR10","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","volume":"176","author":"S Fukada","year":"2010","unstructured":"Fukada, S. et al. Genetic background affects properties of satellite cells and Mdx phenotypes. Am. J. Pathol. 176, 2414\u20132424 (2010).","journal-title":"Am. J. Pathol."},{"key":"17137_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddv460","volume":"25","author":"WD Coley","year":"2016","unstructured":"Coley, W. D. et al. Effect of genetic background on the dystrophic phenotype in Mdx mice. Hum. Mol. Genet. 25, 130\u2013145 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"17137_CR12","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1096\/fj.201802488R","volume":"33","author":"M van Putten","year":"2019","unstructured":"van Putten, M. et al. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy. FASEB J. 33, 8110\u20138124 (2019).","journal-title":"FASEB J."},{"key":"17137_CR13","doi-asserted-by":"publisher","first-page":"14070","DOI":"10.1038\/s41598-020-70987-y","volume":"10","author":"DW Hammers","year":"2020","unstructured":"Hammers, D. W. et al. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. Sci. Rep. 10, 14070 (2020).","journal-title":"Sci. Rep."},{"key":"17137_CR14","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1172\/JCI39845","volume":"119","author":"A Heydemann","year":"2009","unstructured":"Heydemann, A. et al. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J. Clin. Invest. 119, 3703\u20133712 (2009).","journal-title":"J. Clin. Invest."},{"key":"17137_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.23819","volume":"73","author":"KM Flanigan","year":"2013","unstructured":"Flanigan, K. M. et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann. Neurol. 73, 481\u2013488 (2013).","journal-title":"Ann. Neurol."},{"key":"17137_CR16","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1073\/pnas.1324242111","volume":"111","author":"KA Swaggart","year":"2014","unstructured":"Swaggart, K. A. et al. Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc. Natl. Acad. Sci. U S A. 111, 6004\u20136009 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"17137_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1152\/physiolgenomics.00010.2006","volume":"25","author":"S Korff","year":"2006","unstructured":"Korff, S. et al. Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiol. Genomics. 25, 387\u2013392 (2006).","journal-title":"Physiol. Genomics"},{"key":"17137_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omtm.2018.10.005","volume":"11","author":"TL Kennedy","year":"2018","unstructured":"Kennedy, T. L. et al. Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2\/mdx mice. Mol. Ther. Methods Clin. Dev. 11, 92\u2013105 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"17137_CR19","doi-asserted-by":"publisher","first-page":"C1011","DOI":"10.1152\/ajpcell.00638.2023","volume":"326","author":"CA Bellissimo","year":"2024","unstructured":"Bellissimo, C. A. et al. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy. Am. J. Physiol. Cell. Physiol. 326, C1011\u2013C1026 (2024).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"17137_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/JND-180324","volume":"5","author":"H Gordish-Dressman","year":"2018","unstructured":"Gordish-Dressman, H. et al. Of mice and measures: A project to improve how we advance Duchenne muscular dystrophy therapies to the clinic. J. Neuromuscul. Dis. 5, 407\u2013417 (2018).","journal-title":"J. Neuromuscul. Dis."},{"key":"17137_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JND-221547","volume":"10","author":"A Aartsma-Rus","year":"2023","unstructured":"Aartsma-Rus, A., van Putten, M., Mantuano, P. & De Luca, A. On the use of D2.B10-Dmdmdx\/J (D2.mdx) versus C57BL\/10ScSn-Dmdmdx\/J (mdx) mouse models for preclinical studies on Duchenne muscular dystrophy: A cautionary note from members of the TREAT-NMD advisory committee on therapeutics. J. Neuromuscul. Dis. 10, 155\u2013158 (2023).","journal-title":"J. Neuromuscul. Dis."},{"key":"17137_CR22","doi-asserted-by":"publisher","first-page":"a034405","DOI":"10.1101\/cshperspect.a034405","volume":"9","author":"SB Rutkove","year":"2019","unstructured":"Rutkove, S. B. & Sanchez, B. Electrical impedance methods in neuromuscular assessment: an overview. Cold Spring Harb Perspect. Med. 9, a034405 (2019).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"17137_CR23","first-page":"10379163513","volume":"84","author":"M Mortreux","year":"2022","unstructured":"Mortreux, M. et al. Performing in vivo and ex vivo electrical impedance myography in rodents. J. Vis. Exp. 84, 10379163513 (2022).","journal-title":"J. Vis. Exp."},{"key":"17137_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11910-017-0793-3","volume":"17","author":"B Sanchez","year":"2017","unstructured":"Sanchez, B., Rutkove, S. B. & Present Uses Future applications, and technical underpinnings of electrical impedance myography. Curr. Neurol. Neurosci. Rep. 17, 86 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"17137_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/17482968.2012.688837","volume":"13","author":"SB Rutkove","year":"2012","unstructured":"Rutkove, S. B. et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph. Lateral Scler. 13, 439\u2013445 (2012).","journal-title":"Amyotroph. Lateral Scler."},{"key":"17137_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/mus.23233","volume":"45","author":"SB Rutkove","year":"2012","unstructured":"Rutkove, S. B., Gregas, M. C. & Darras, B. T. Electrical impedance myography in spinal muscular atrophy: a longitudinal study. Muscle Nerve. 45, 642\u2013647 (2012).","journal-title":"Muscle Nerve"},{"key":"17137_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.24874","volume":"81","author":"SB Rutkove","year":"2017","unstructured":"Rutkove, S. B. et al. Electrical impedance myography for assessment of Duchenne muscular dystrophy. Ann. Neurol. 81, 622\u2013632 (2017).","journal-title":"Ann. Neurol."},{"key":"17137_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/acn3.50958","volume":"7","author":"ML Leitner","year":"2020","unstructured":"Leitner, M. L. et al. Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trials. Ann. Clin. Transl Neurol. 7, 4\u201314 (2020).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"17137_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.24086","volume":"49","author":"J Li","year":"2014","unstructured":"Li, J. et al. Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle. Muscle Nerve. 49, 829\u2013835 (2014).","journal-title":"Muscle Nerve"},{"key":"17137_CR30","doi-asserted-by":"publisher","first-page":"e0140521","DOI":"10.1371\/journal.pone.0140521","volume":"10","author":"B Sanchez","year":"2015","unstructured":"Sanchez, B. et al. Evaluation of electrical impedance as a biomarker of myostatin Inhibition in wild type and muscular dystrophy mice. PLoS One. 10, e0140521 (2015).","journal-title":"PLoS One"},{"key":"17137_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13395-023-00331-1","volume":"13","author":"T Hiyoshi","year":"2023","unstructured":"Hiyoshi, T. et al. Electrical impedance myography detects dystrophin-related muscle changes in Mdx mice. Skelet. Muscle. 13, 19 (2023).","journal-title":"Skelet. Muscle"},{"key":"17137_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3233\/JND-210787","volume":"10","author":"SM Chrzanowski","year":"2023","unstructured":"Chrzanowski, S. M., Nagy, J. A., Pandeya, S. & Rutkove, S. B. Electrical impedance myography correlates with functional measures of disease progression in D2-mdx mice and boys with Duchenne muscular dystrophy. J. Neuromuscul. Dis. 10, 81\u201390 (2023).","journal-title":"J. Neuromuscul. Dis."},{"key":"17137_CR33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mus.27240","volume":"63","author":"SR Pandeya","year":"2021","unstructured":"Pandeya, S. R. et al. Estimating myofiber cross-sectional area and connective tissue deposition with electrical impedance myography: A study in D2-mdx mice. Muscle Nerve. 63, 941\u2013950 (2021).","journal-title":"Muscle Nerve"},{"key":"17137_CR34","doi-asserted-by":"publisher","first-page":"1025528","DOI":"10.3389\/fvets.2022.1025528","volume":"9","author":"SA Verga","year":"2022","unstructured":"Verga, S. A. et al. Electrical impedance myography in healthy dogs: normative values, repeatability, and the impact of age. Front. Vet. Sci. 9, 1025528 (2022).","journal-title":"Front. Vet. Sci."},{"key":"17137_CR35","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1016\/j.clinph.2016.09.017","volume":"127","author":"SB Rutkove","year":"2016","unstructured":"Rutkove, S. B. et al. Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that May serve as a convenient index of disease status. Clin. Neurophysiol. 127, 3546\u20133551 (2016).","journal-title":"Clin. Neurophysiol."},{"key":"17137_CR36","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/biomedicines11071938","volume":"11","author":"SB Rutkove","year":"2023","unstructured":"Rutkove, S. B. et al. Surface electrical impedance myography detects skeletal muscle atrophy in aged wildtype zebrafish and aged gpr27 knockout zebrafish. Biomedicines 11, 1938 (2023).","journal-title":"Biomedicines"},{"key":"17137_CR37","doi-asserted-by":"publisher","first-page":"1119888","DOI":"10.3389\/fimmu.2023.1119888","volume":"14","author":"B Boccanegra","year":"2023","unstructured":"Boccanegra, B. et al. A. Growth hormone secretagogues modulate inflammation and fibrosis in Mdx mouse model of Duchenne muscular dystrophy. Front. Immunol. 14, 1119888 (2023).","journal-title":"Front. Immunol."},{"key":"17137_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nmd.2010.02.004","volume":"20","author":"M van Putten","year":"2010","unstructured":"van Putten, M. et al. A 3 months mild functional test regime does not affect disease parameters in young Mdx mice. Neuromuscul. Disord. 20, 273\u2013280 (2010).","journal-title":"Neuromuscul. Disord"},{"key":"17137_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland, J. M. & Altman, D. G. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 8, 135\u2013160 (1999).","journal-title":"Stat. Methods Med. Res."},{"key":"17137_CR40","doi-asserted-by":"crossref","unstructured":"Hakim, C. H. et al. Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography. PloS One, 12(3), e0173557 (2017).","DOI":"10.1371\/journal.pone.0173557"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17137-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:29:46Z","timestamp":1758886186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17137-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Rutkove has equity in and serves as a consultant and scientific advisor to Myolex Inc., a company that designs impedance devices for clinical and research use and used in this study; he is also a member of Myolex\u2019s Board of Directors. The company also has an option to license patented impedance technology of which Dr. Rutkove is named as an inventor. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33210"}}